View in EDS

Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers.

Saved in:
Bibliographic Details
Title: Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers.
Authors: Myojin Y; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., McCallen JD; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Ma C; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Bauer KC; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Ruf B; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Benmebarek MR; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Green BL; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Wabitsch S; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., McVey JC; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Fu C; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Xie C; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Greten TF; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.
Source: JHEP reports : innovation in hepatology [JHEP Rep] 2023 Nov 03; Vol. 6 (1), pp. 100959. Date of Electronic Publication: 2023 Nov 03 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38192537
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Myojin+Y%22">Myojin Y</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22McCallen+JD%22">McCallen JD</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Ma+C%22">Ma C</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Bauer+KC%22">Bauer KC</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Ruf+B%22">Ruf B</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Benmebarek+MR%22">Benmebarek MR</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Green+BL%22">Green BL</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Wabitsch+S%22">Wabitsch S</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22McVey+JC%22">McVey JC</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Fu+C%22">Fu C</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Xie+C%22">Xie C</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.<br /><searchLink fieldCode="AU" term="%22Greten+TF%22">Greten TF</searchLink>; Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761237%22">JHEP reports : innovation in hepatology</searchLink> [JHEP Rep] 2023 Nov 03; Vol. 6 (1), pp. 100959. <i>Date of Electronic Publication: </i>2023 Nov 03 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101761237 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5559 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895559%22">25895559 </searchLink><i>NLM ISO Abbreviation: </i>JHEP Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38192537
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jhepr.2023.100959
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100959
    Titles:
      – TitleFull: Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Myojin Y
      – PersonEntity:
          Name:
            NameFull: McCallen JD
      – PersonEntity:
          Name:
            NameFull: Ma C
      – PersonEntity:
          Name:
            NameFull: Bauer KC
      – PersonEntity:
          Name:
            NameFull: Ruf B
      – PersonEntity:
          Name:
            NameFull: Benmebarek MR
      – PersonEntity:
          Name:
            NameFull: Green BL
      – PersonEntity:
          Name:
            NameFull: Wabitsch S
      – PersonEntity:
          Name:
            NameFull: McVey JC
      – PersonEntity:
          Name:
            NameFull: Fu C
      – PersonEntity:
          Name:
            NameFull: Xie C
      – PersonEntity:
          Name:
            NameFull: Greten TF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2023 Nov 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2589-5559
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: JHEP reports : innovation in hepatology
              Type: main
ResultId 1